Navigation Links
Veran Medical Technologies Launches New SPiN Drive™ Application for Bi-Planar Virtual Fluoroscopy View
Date:12/16/2011

ST. LOUIS, Dec. 16, 2011 /PRNewswire/ -- Veran Medical Technologies announced today the release of its SPiN Drive™ platform upgrade for bi-planar virtual fluoroscopy view used to navigate multiple planes simultaneously. This advancement is the first of its kind in pulmonology, enabling physicians to view the location of the Always-On Tip Tracked™ instrument in a fluoro-like view without any radiation being delivered to the patient, physician or staff.

(Logo:  http://photos.prnewswire.com/prnh/20111216/CG24275)

"The significance of targeting Solitary Pulmonary Nodules (SPNs) without radiation is exciting," said Alexander C. Chen, M.D., of Washington University, St. Louis, MO. "The virtual fluoroscopic view provides images that the majority of bronchoscopists utilize while targeting solitary pulmonary nodules, without the radiation exposure. Additionally, the ability to map airways during procedures may provide a significant advantage towards targeting SPNs."

"This enhancement is ground-breaking technology," said Mark Hunter, vice president of strategic operations at Veran Medical Technologies. "Auto-rotate fly-through view makes instrument steering more intuitive and consistent with the user's standard bronchoscopic view."

Lung cancer is a deadly disease that mortally claims 85 percent of patients within five years. Diagnosing lung cancer at Stage I improves survival chances significantly. Due to the 69 million CT scans that occur annually in the United States, inadvertent lung cancer screening is occurring. However, SPNs in the peripheral lung are inaccessible with today's techniques and technologies, leaving patients on "watchful waiting" protocols of repeat CT scanning causing significant patient anxiety and unproductive costs added to the U.S. healthcare system. Veran's SPiN Drive™ product acts as a GPS-like system to enable pulmonologists and surgeons to access SPNs and immediately diagnose malignancy, end watchful waiting and reduce healthcare spending.

About Veran Medical Technologies, Inc.

Veran Medical Technologies is a privately held company led by a team of innovators focused on developing the next standard of care for minimally invasive delivery of interventional oncology therapies. Veran has built several clinical products upon its ig4™ platform technology, which uses proprietary 4D registration capabilities for targeting lesions within the human body. The company believes that by enabling minimally invasive early stage treatments, it can increase patient survival and lower healthcare costs significantly. Veran Medical Technologies is headquartered in St. Louis, MO.

www.veranmedical.com


'/>"/>
SOURCE Veran Medical Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Veran Medical Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive(TM) System
2. VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System
3. Saladax Biomedical, Inc. Expands Distribution of My5-FU in Europe
4. MD+DI, the Global MedTech Industry Authority, Highlights the Human Element in Medical Device Design: Designing the Devices Surgeons Want and Pushing the Boundaries of Innovation
5. Dehaier Medical Enters European Homecare Medical Product Market
6. Kensey Nash to Enter Into Mediation with St. Jude Medical over Angio-Seal Contract Disputes
7. Concord Medical to Present at the 30th Annual J.P. Morgan Healthcare Conference in January 2012
8. Medical Device Costa Rica: An MPO Symposium Helps Firms Connect, Learn & Master Global Manufacturing Skills
9. TransTech Medical Solutions Ranked #1 by KLAS for 2011
10. FDA, Austen BioInnovation Institute to Collaborate on the Safety and Performance of Materials used in Medical Devices
11. MedShape, Inc. Awarded U.S. Patent for Deploying Shape Memory Polymer Devices in Medical Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... TapImmune,Inc. (TPIV), a clinical-stage ... gene-based immunotherapeutics and vaccines for the treatment of cancer & ... 3rd Annual Growth Capital Expo to be held ... Caesars Palace in Las Vegas, Nevada.  The Company presentation ... th by Dr. John N. Bonfiglio a ...
(Date:4/27/2016)... , le 27 Avril 2016 ... d,affaires a progressé de +5% sur le trimestre, ... récurrentes de consommables  Croissance de +16% ... Mauna Kea Technologies (Euronext : MKEA, ... d,endomicroscopie confocale laser, annonce aujourd,hui son chiffre d,affaires ...
(Date:4/27/2016)...   Zillion Group today announced the ... which specializes in live video consultation. Turning content, ... Zillion enables companies to realize the true potential ... control of their health. Zillion,s ... one-to-one, group and webcast scheduled or on-demand – ...
Breaking Medicine Technology:
(Date:4/29/2016)... STAMFORD, CONNECTICUT (PRWEB) , ... April 29, 2016 , ... ... 5K Run/Walk” at Cove Island Park on Sunday, with sunny skies, a light breeze ... event, raising nearly $33,000. , The 5k Run and Walk and 1-mile ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... surgeon reveals that infants born with severe congenital diaphragmatic hernia have better survival ... born with congenital diaphragmatic hernia (CDH)—a condition where the diaphragm fails to form ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... won the $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan ... the Michelson People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ ...
(Date:4/29/2016)... New York, NY (PRWEB) , ... April 29, ... ... integrated manufacturer and engineer of patented products, announces the Gyrociser, an exercise invention ... industry is worth $2 billion," says Scott Cooper, CEO and Creative Director of ...
(Date:4/29/2016)... Tarzana, CA (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type ... is to blame for the majority of skin cancer deaths. More than 10,000 people are ... average age at diagnosis is 62, it is the one of the most commonly diagnosed ...
Breaking Medicine News(10 mins):